Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.56M | 5.95M | 7.23M | 9.02M | 10.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.31M | 10.39M | 13.06M | 18.52M | 21.70M |
| Operating Income | -8.31M | -10.39M | -13.06M | -18.52M | -21.70M |
| Income Before Tax | -30.94M | -32.87M | -36.29M | -41.56M | -23.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.94 | -32.87 | -36.29 | -41.56 | -23.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -3.23M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.94M | -32.87M | -36.29M | -41.56M | -26.32M |
| EBIT | -8.31M | -10.39M | -13.06M | -18.52M | -21.70M |
| EBITDA | -8.23M | -10.31M | -12.97M | -18.43M | -21.63M |
| EPS Basic | -0.08 | -0.08 | -0.09 | -0.11 | -0.08 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 |
| EPS Diluted | -0.08 | -0.08 | -0.09 | -0.11 | -0.08 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 1.65B | 1.63B | 1.58B | 1.46B | 1.34B |
| Average Diluted Shares Outstanding | 1.65B | 1.63B | 1.58B | 1.46B | 1.34B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |